Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why the Spotlight is Shining on Amazon, Teva, Bank of America, and More Today

Page 1 of 2

Interest rate-sensitive financial stocks are in the spotlight today after previously-dovish Boston Federal Reserve President Eric Rosengren said that “a reasonable case can be made” for hiking rates, albeit gradually.

Given the development, it’s not surprising that several financial stocks are on our list of the day’s biggest newsmakers. In this article, we’ll analyze the events causing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA),, Inc. (NASDAQ:AMZN), Bank of America Corp (NYSE:BAC), E*TRADE Financial Corp (NASDAQ:ETFC), and Citigroup Inc (NYSE:C) to trend and use the latest 13F data to determine how hedge funds are positioned among the five equities.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).


Traders are talking about Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) today after the drug company gave a relatively upbeat presentation on its generic business on Friday. According to the company, Teva currently leads the global generic market, with 8% market share powered by a global portfolio of 16,000 products that average around $14 billion-to-$15 billion in sales when not including OTC. There is growth ahead as well, as Teva’s management believes that the global generic market will grow to $292 billion in 2020 from $220 billion in 2016 as the tailwinds of an aging population and increasing diagnosis/treatment rates spur demand. Bulls hope Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) can take advantage of the growing demand and successfully unlock synergies from its $40.5 billion Actavis Generics acquisition, which recently closed. Andreas Halvorsen‘s Viking Global reported holding a stake of over 27 million shares in the generic drug producer as of the end of June.

Follow Teva Pharmaceutical Inds Ltd (NYSE:TEVA)
Trade (NYSE:TEVA) Now!

In its quest to take more market-share from Netflix, Inc. (NASDAQ:NFLX),, Inc. (NASDAQ:AMZN) is reportedly interested in seeking the rights to stream live sports anywhere, from professional rugby to the French Open. In addition, the company is interested in streaming baseball and basketball, although the rights to those popular sports have largely been taken for many years by traditional media companies. By buying the rights to live sports, Amazon could differentiate itself from Netflix and capture more of the cord-cutting audience. 145 funds in our system were long, Inc. (NASDAQ:AMZN) as of the most recent 13F reporting period.

Follow Amazon Com Inc (NASDAQ:AMZN)
Trade (NASDAQ:AMZN) Now!

On the next page, we’ll examine financial stocks Bank of America, E*TRADE Financial, and Citigroup.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!